🇧🇪 Belgium Country × Condition
solid tumors Clinical Trials in Belgium
Active clinical trials for solid tumors with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇧🇪 Belgium
Active Trials in Belgium (3)
NCT06644755 Phase 1
Recruiting
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Enrollment
150 pts
Country
🇧🇪 Belgium
Daiichi Sankyo
View Trial → NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Enrollment
170 pts
Country
🇧🇪 Belgium
Mirati Therapeutics Inc.
View Trial → NCT07195916 Phase 1
Recruiting
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Enrollment
280 pts
Country
🇧🇪 Belgium
Incyte Corporation
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in Belgium?
There are currently 3 active clinical trials for solid tumors with sites in Belgium, of which 3 are actively recruiting patients.
How can I join a solid tumors clinical trial in Belgium?
To join a solid tumors clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in Belgium?
Active solid tumors trials in Belgium span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology